Nymox Pharmaceutical
NYMX
#10343
Rank
โ‚น1.73 B
Marketcap
Country
โ‚น18.98
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -โ‚น4.92

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -โ‚น5.69. In 2022 the company made an earnings per share (EPS) of -โ‚น7.59 an increase over its 2021 EPS that were of -โ‚น14.24.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น4.92-35.21%
2022-โ‚น7.59-46.67%
2021-โ‚น14.24-11.76%
2020-โ‚น16.13-15%
2019-โ‚น18.985.26%
2018-โ‚น18.03-26.92%
2017-โ‚น24.68-7.14%
2016-โ‚น26.57-40.43%
2015-โ‚น44.61291.67%
2014-โ‚น11.39-7.69%
2013-โ‚น12.34-43.48%
2012-โ‚น21.83-25.81%
2011-โ‚น29.4255%
2010-โ‚น18.9825%
2009-โ‚น15.190.08%
2008-โ‚น15.17-11.12%
2007-โ‚น17.07-0.16%
2006-โ‚น17.1028.59%
2005-โ‚น13.30-12.49%
2004-โ‚น15.20-16.05%
2003-โ‚น18.1019.07%
2002-โ‚น15.2014.45%
2001-โ‚น13.28-22.16%
2000-โ‚น17.065.64%
1999-โ‚น16.15-34.59%
1998-โ‚น24.70-3.6%
1997-โ‚น25.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,057-18,664.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น129.08-2,366.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น355.94-6,350.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,185-38,474.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น841.85-14,883.33%๐Ÿ‡บ๐Ÿ‡ธ USA